Trump Administration Unveils ‘TrumpRx’ Website, Secures Landmark Pfizer Drug Pricing Deal

The Trump administration yesterday announced a significant push to reduce prescription drug costs for Americans, including the planned launch of a new “TrumpRx” website and a major agreement with pharmaceutical giant Pfizer.

Speaking from the Oval Office on September 30, 2025, President Donald Trump revealed that the “TrumpRx” website, anticipated to be available in early 2026, aims to offer discounted prescription medications directly to consumers, bypassing traditional insurance channels. This initiative is designed to improve healthcare access, particularly for low-income Americans, by allowing them to purchase medications at the lowest available prices.

This announcement closely follows a similar move by PhRMA, the pharmaceutical industry’s leading trade group, which also unveiled a direct-to-consumer sales website slated for January 2026.

In a related development, the administration secured a landmark agreement with Pfizer. Under this deal, Pfizer has committed to charging the U.S. no more than other countries for its drugs sold via Medicare, Medicaid, or cash payments. This agreement is a direct result of an executive order signed by Trump in May, which advocated for “most favored nation” drug pricing. As part of the deal, Pfizer will avoid tariffs for three years and has pledged a $70 billion investment to enhance U.S. manufacturing capabilities.

President Trump was joined by notable figures for the announcement, including Pfizer CEO Albert Bourla, Health and Human Services Secretary Robert F. Kennedy Jr., CMS Administrator Mehmet Oz, and FDA Commissioner Martin Makary. While the full impact on individuals with private insurance is yet to be determined, these developments are heralded by the administration as a crucial step towards making healthcare more affordable and accessible nationwide.

阅读中文版 (Read Chinese Version)

Disclaimer: This content is aggregated from public sources online. Please verify information independently. If you believe your rights have been infringed, contact us for removal.